This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Entropion of the eyelid

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

This is the turning inwards of the eyelid. Involutional, spastic or senile entropion always affects the lower lid. It is caused by atrophic changes in the lower lid retractors, tarsal plate and adjacent fat in which the marginal fibres of the orbicularis oculi contract more strongly than the peripheral fibres. It can be elicited by asking the patient to squeeze the eyes tightly shut; upon opening, the lower lid will be seen to be turned inwards.

Cicatricial entropion may affect either the upper or the lower lid. It results from conjunctival and tarsal scar formation, for example, due to burns, Stevens - Johnson's syndrome, and trachoma.

Congenital entropion is rare. It results from rotation of the lid margin towards the cornea. It is to be distinguished from an epiblepharon in which the pretarsal skin and muscle causes the lashes to rotate around the tarsal border. Epiblepharon is most common in Asians.

Irrespective of the initial cause, the condition is exacerbated by the inturned eyelashes causing conjunctival and corneal irritation, leading to further entropion.

Sedatives and lubricants may give some relief. Surgery designed to lengthen the lower fibres of the orbicularis or to weaken the marginal fibres is the treatment of choice. If there is irritation from the lashes, these may be removed and a contact lens worn.

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.


Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.